Researchers at Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Harvard Medical School have made an important discovery about the hepatitis B virus (HBV) that could lead ...
Temporomandibular joint osteoarthritis (TMJOA) is a debilitating condition characterized by severe joint pain, restricted mobility, and progressive cartilage degradation. Despite its significant ...
In this interview with Dr. Susanne Back, Associate Director of Central Nervous System (CNS) Pharmacology at Charles River Laboratories, we delve into the growing significance of antisense ...
Temporomandibular joint osteoarthritis (TMJOA) is a debilitating condition that causes severe joint pain, restricted mobility, and progressive cartilage degradation. Despite its significant impact on ...
ETH Zurich researchers have explored how minuscule gas bubbles can deliver drugs into cells precisely using ultrasound technology. For the first time, they've visualized how tiny liquid jets produced ...
We are pleased to announce the publication of a new article in the Cardiovascular Innovations and Applications journal, which explores the potential benefits of opioid-sparing anesthesia (OSA) for ...
If you have any complaints regarding products regulated by the U.S. Food and Drug Administration (FDA), the agency encourages you to share your experiences. The FDA provides several methods for ...
A groundbreaking new artificial intelligence model has been developed by researchers at the USC Leonard Davis School of Gerontology and King's College London. This innovative tool is capable of ...
Despite ongoing concerns regarding potential plans by Congress and the Trump administration to alter Medicaid, Montana's Republican-led legislature appears committed to maintaining its expanded ...
A groundbreaking study published in BMJ Oncology challenges previous assumptions about the role of BRCA1 gene mutations—both inherited (germline) and acquired (somatic)—in initiating prostate cancer. ...
Starting today, individuals diagnosed with Parkinson's disease will have access to a revolutionary new treatment option thanks to the U.S. Food and Drug Administration (FDA) approving groundbreaking ...
When doctors collaborated with an artificial intelligence tool designed to listen in on patient consultations and take notes during visits, they observed a significant reduction in the amount of time ...
